Histogen's Series B Round

Histogen raised a round of funding on December 01, 2010.

Histogen is a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a bioreactor that mimics the embryonic environment. Histogen has developed a rich pro…

Articles about Histogen's Series B Round: